John LM , Lechleiter JD , Camacho P .

R01 GM55372 NIGMS NIH HHS , R01 GM055372 NIGMS NIH HHS

	Figure 2. Overexpression of GFP-SERCA2 fusion constructs reveals functional differences in SERCA2a and SERCA2b. (a) Cartoon view of the fusion constructs used to tag SERCA isoforms at the NH2 terminus with the S65T increased fluorescence mutant of GFP. (b) Western blot analysis demonstrates overexpression of GFP-SERCA2 fusion products detected by probing the membrane with a polyclonal anti-SERCA2 antibody that was raised in rabbit against a recombinant His-tagged fragment encompassing most of the cytoplasmic loop between M4 and M5 from rat SERCA2 (N1, gift of J. Lytton). Wild-type SERCA2a and SERCA2b (lanes 1 and 3, respectively) migrated ∼27 kD below fusion protein products contained in extracts from oocytes overexpressing GFP-SERCA2a and GFP-SERCA2b (lanes 2 and 4, respectively). Oocyte extracts from control oocytes (H2O replacing mRNA) were run on lane 5. Molecular size markers (in kD) are indicated on the left (Kaleidoscope; Bio-Rad Laboratories). (c) High magnification confocal images of GFP fluorescence in oocytes overexpressing GFP-SERCA2a and GFP-SERCA2b fusion proteins (left and middle, respectively). Note that fluorescence is confined to the ER corridors between yolk platelets. A control oocyte overexpressing cytosolic GFP is shown (right). In this oocyte, fluorescence is more diffuse. Images are 52 μm × 36 μm, and were acquired with an OZ confocal laser scanning microscope (Noran Instruments, Middleton, WI). The oocytes were excited at 488 nm and imaged with a 60× water immersion objective. Bar, ∼10 μm.
	Figure 5. ΔC inhibition of repetitive Ca2+ waves and reversal of the ΔC effect by glucosidase inhibitors. (a) The percent of oocytes exhibiting repetitive Ca2+ oscillations is significantly reduced in oocytes coexpressing ΔC with SERCA2b (black bars), but not in oocytes coexpressing ΔC with SERCA2a (gray bars; **P < 0.01, Chi-squared test). Of those oocytes that did display repetitive Ca2+ oscillations, the interwave period (middle histogram) and decay time (right histogram) were significantly increased in oocytes coexpressing ΔC with SERCA2b when compared with control oocytes overexpressing SERCA2b alone (*P < 0.005). No significant differences were found between oocytes coexpressing ΔC with SERCA2a as compared with control oocytes overexpressing SERCA2a alone in either interwave period or in decay time of individual waves. Note that there is a change in scale values for the ordinate in histograms of wave period and decay time with respect to Fig. 3 c. The larger scale in this figure reflects the longer period and longer decay time of Ca2+ waves in SERCA2b + ΔC-overexpressing oocytes. (b) Western blot analysis demonstrates overexpression of the ΔC mutant of CRT in fractions from oocytes coexpressing this calreticulin mutant with SERCA2a (lane 1) and SERCA2b (lane 2). Oocyte extracts from control oocytes (H2O replacing mRNA) were run on lane 3. The membrane was probed with a primary anti-CRT KDEL Ab that recognizes the last six amino acids at the COOH terminus of rabbit CRT (gift of Michalak). (c) Glucosidase inhibition antagonizes the effects of ΔC overexpression on oscillatory Ca2+ waves. Period between waves in SERCA2b + ΔC-overexpressing oocytes is significantly decreased (n = 13) in oocytes injected with 1 mM final DNJ (Toronto Research Chemicals, North York, Ontario, Canada) when compared with uninjected SERCA2b + ΔC control oocytes (n = 18). **Indicates statistical significance at P < 0.025. In the same groups of oocytes, decay time of individual Ca2+ waves is also reduced, although the differences are not statistically significant.
	Figure 3. GFP-SERCA2 isoforms retain the characteristics of their respective unmodified proteins and at equivalent levels of expression exhibit different Ca2+ wave characteristics. (a) Fluorescence images in GFP-SERCA2a (left) and GFP-SERCA2b (middle) overexpressing oocytes that have been matched for equivalent levels of GFP fluorescence intensity. GFP fluorescence (745 μm × 530 μm) was excited at 488 nm. Note that under these imaging conditions, fluorescence levels in control oocytes (injected with H2O instead of GFP-SERCA2 mRNA) are not detectable. For quantitation of overexpression levels of GFP fusion proteins, fluorescence values were measured from images obtained at a low magnification (10× objective; bar, ∼100 μm). (b) Spatio-temporal patterns (left) of Ca2+ release induced by injection of IP3 (∼300 nM final) in oocytes as labeled. In this experiment, Ca2+ Orange (Molecular Probes, Inc.) was used as indicator of Ca2+ wave activity so that GFP fluorescence and Ca2+ wave activity could be observed in the same oocyte. GFP(S65T) absorption and emission maxima in the visible spectrum occur at 490 and 509 nm, respectively, while for Ca2+ Orange these are 590 nm and 650 nm, respectively. Thus, for the imaging parameters used, Ca2+ Orange fluorescence does not overlap with GFP fluorescence emission. Each temporal stack contains 400 images taken at 0.5-s intervals. A single image (530 μm × 745 μm) of Ca2+ wave activity is shown at the indicated time (right). (c) At equivalent levels of GFP fluorescence, the Ca2+ wave properties are different for oocytes overexpressing GFP-SERCA2a (gray bars, n = 13) and GFP-SERCA2b (black bars, n = 10). Histogram of GFP fluorescence (left) shows fluorescence intensity measurements in arbitrary units. Histogram of Ca2+ wave period (middle) and Ca2+ wave decay time (right) measure each of these parameters from the time course of the average fluorescence intensity of a 5 × 5 pixel area. Note that GFP-SERCA2a-overexpressing oocytes display a higher Ca2+ wave frequency (i.e., shorter periods) than the GFP-SERCA2b-overexpressing oocytes. * Indicates a statistically significant difference at P < 0.005.
	Figure 4. ΔC inhibits Ca2+ oscillations when coexpressed with SERCA2b, but not when coexpressed with SERCA2a. (a and b) Comparison of the IP3 (∼300 nM)-induced Ca2+ wave activity in a SERCA2b-overexpressing oocyte with the Ca2+ wave activity of a SERCA2b + ΔC-coexpressing oocyte. (c and d) Comparison of the IP3 (∼300 nM)-induced Ca2+ wave activity in a SERCA2a-overexpressing oocyte with the Ca2+ wave activity of a SERCA2a + ΔC-coexpressing oocyte. Individual confocal images (745 μm × 745 μm) of Ca2+ wave activity were taken at the indicated times. The bottom trace in each panel represents the change in fluorescence (ΔF/F) shown as a function of time for a 5 × 5 pixel area (white square in the first panel of each image).
	Figure 6. Site-directed mutagenesis of SERCA2b residue N1036 creates a protein that is no longer responsive to ΔC coexpression, and that resembles SERCA2a. (a) Amino acid sequence comparison between the COOH terminus of SERCA2a and SERCA2b. The eleventh transmembrane segment of SERCA2b is shown (hatched). The consensus N-linked glycosylation motif is underlined, and the mutated residue N1036A is indicated in bold. (b) Comparison of Ca2+ wave activity in two oocytes overexpressing SERCA2bN1036A (top) or SERCA2bN1036A + ΔC (bottom). (c) The left histogram shows percent of oocytes exhibiting repetitive Ca2+ oscillations when SERCA2bN1036A is expressed alone or with ΔC. Of those oocytes that displayed repetitive Ca2+ oscillations, no significant differences were found in either interwave period (middle histogram) or in decay time (right histogram) between oocytes coexpressing ΔC with SERCA2bN1036A and control oocytes overexpressing SERCA2bN1036A alone. These results are similar to those observed for SERCA2a and SERCA2a + ΔC-overexpressing oocytes (see Fig. 4 b). (d) Western blot analysis demonstrates overexpression of ΔC in fractions from SERCA2bN1036A + ΔC oocytes (lane 1). No detectable CRT product was observed in extracts from control oocytes (H2O replacing mRNA) (lane 2). The membrane was probed with the anti-CRT KDEL primary Ab from Fig. 4 c.
	Figure 7. Residue N1036 is critical in determining the functional differences between SERCA2 isoforms. (a) Differential migration patterns between SERCA2bN1036A (lane 1) vs. GFP-SERCA2bN1036A (lane 2) on a Western blot probed with the same N1 anti-SERCA2 Ab from Fig. 2 b. Fractions from control oocytes (H2O replacing mRNA) were run on lane 3. (b) Confocal images of GFP fluorescence intensity at high resolution (60× objective; 52 μm × 36 μm) and at low resolution (10× objective; 745 μm × 530 μm) in a GFP-SERCA2bN1036A oocyte matched for GFP fluorescence intensity with the oocytes shown in Fig. 3 a. (c) Spatiotemporal stack (left) of Ca2+ wave activity from the GFP-SERCA2bN1036A overexpressing oocyte in b. Confocal image of Ca2+ wave activity at the indicated time (right). Imaging parameters were similar to those described in Fig. 3 b.

Baksh, Interaction of calreticulin with protein disulfide isomerase. 1995, Pubmed

Baksh, Interaction of calreticulin with protein disulfide isomerase. 1995, Pubmed
Bastianutto, Overexpression of calreticulin increases the Ca2+ capacity of rapidly exchanging Ca2+ stores and reveals aspects of their lumenal microenvironment and function. 1995, Pubmed
Bayle, The membrane topology of the rat sarcoplasmic and endoplasmic reticulum calcium ATPases by in vitro translation scanning. 1995, Pubmed
Bergeron, Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. 1994, Pubmed
Berridge, Inositol trisphosphate and calcium signalling. 1993, Pubmed
Bezprozvanny, The inositol 1,4,5-trisphosphate (InsP3) receptor. 1995, Pubmed
Bezprozvanny, Bell-shaped calcium-response curves of Ins(1,4,5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. 1991, Pubmed
Boitano, Intercellular propagation of calcium waves mediated by inositol trisphosphate. 1992, Pubmed
Brandl, Two Ca2+ ATPase genes: homologies and mechanistic implications of deduced amino acid sequences. 1986, Pubmed
Burk, cDNA cloning, functional expression, and mRNA tissue distribution of a third organellar Ca2+ pump. 1989, Pubmed
Camacho, Increased frequency of calcium waves in Xenopus laevis oocytes that express a calcium-ATPase. 1993, Pubmed , Xenbase
Camacho, Calreticulin inhibits repetitive intracellular Ca2+ waves. 1995, Pubmed , Xenbase
Clapham, Calcium signaling. 1995, Pubmed
Clarke, The epitope for monoclonal antibody A20 (amino acids 870-890) is located on the luminal surface of the Ca2(+)-ATPase of sarcoplasmic reticulum. 1990, Pubmed
Coppolino, Calreticulin is essential for integrin-mediated calcium signalling and cell adhesion. 1997, Pubmed
Cornell-Bell, Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. 1990, Pubmed
Dani, Neuronal activity triggers calcium waves in hippocampal astrocyte networks. 1992, Pubmed
DeLisle, Inositol trisphosphate is required for the propagation of calcium waves in Xenopus oocytes. 1992, Pubmed , Xenbase
Finch, Calcium as a coagonist of inositol 1,4,5-trisphosphate-induced calcium release. 1991, Pubmed
Fliegel, Molecular cloning of the high affinity calcium-binding protein (calreticulin) of skeletal muscle sarcoplasmic reticulum. 1989, Pubmed
Furuichi, Inositol 1, 4, 5-trisphosphate receptor-mediated Ca2+ signaling in the brain. 1995, Pubmed
Gill, Calcium pools, calcium entry, and cell growth. 1996, Pubmed
Groves, Role of N-glycosylation in the expression of human band 3-mediated anion transport. 1994, Pubmed , Xenbase
Gunteski-Hamblin, A novel Ca2+ pump expressed in brain, kidney, and stomach is encoded by an alternative transcript of the slow-twitch muscle sarcoplasmic reticulum Ca-ATPase gene. Identification of cDNAs encoding Ca2+ and other cation-transporting ATPases using an oligonucleotide probe derived from the ATP-binding site. 1988, Pubmed
Hammond, Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. 1994, Pubmed
Hammond, Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus. 1994, Pubmed
Hausen, The use of polyacrylamide as an embedding medium for immunohistochemical studies of embryonic tissues. 1981, Pubmed
Hebert, Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum. 1995, Pubmed
Heim, Improved green fluorescence. 1995, Pubmed
Helenius, How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. 1994, Pubmed
Iino, Biphasic Ca2+ dependence of inositol 1,4,5-trisphosphate-induced Ca release in smooth muscle cells of the guinea pig taenia caeci. 1990, Pubmed
Krause, Calreticulin. 1997, Pubmed
Lechleiter, Molecular mechanisms of intracellular calcium excitability in X. laevis oocytes. 1992, Pubmed , Xenbase
Lièvremont, Intracellular calcium stores and inositol 1,4,5-trisphosphate receptor in rat liver cells. 1996, Pubmed
Liu, Decreasing calreticulin expression lowers the Ca2+ response to bradykinin and increases sensitivity to ionomycin in NG-108-15 cells. 1994, Pubmed
Longin, Comparison of anti-fading agents used in fluorescence microscopy: image analysis and laser confocal microscopy study. 1993, Pubmed
Lytton, Functional comparisons between isoforms of the sarcoplasmic or endoplasmic reticulum family of calcium pumps. 1992, Pubmed
Lytton, Molecular cloning of cDNAs from human kidney coding for two alternatively spliced products of the cardiac Ca2+-ATPase gene. 1988, Pubmed
MacLennan, Amino-acid sequence of a Ca2+ + Mg2+-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence. , Pubmed
MacLennan, The mechanism of Ca2+ transport by sarco(endo)plasmic reticulum Ca2+-ATPases. 1997, Pubmed
Mahoney, Independent modes of propagation of calcium waves in smooth muscle cells. 1993, Pubmed
Michalak, Calreticulin. 1992, Pubmed
Nathanson, Ca2+ waves are organized among hepatocytes in the intact organ. 1995, Pubmed
Nauseef, Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. 1995, Pubmed
Nigam, A set of endoplasmic reticulum proteins possessing properties of molecular chaperones includes Ca(2+)-binding proteins and members of the thioredoxin superfamily. 1994, Pubmed
NULL, Calnexin, calreticulin and the folding of glycoproteins. 1997, Pubmed
Ohsako, Molecular cloning and sequencing of calnexin-t. An abundant male germ cell-specific calcium-binding protein of the endoplasmic reticulum. 1994, Pubmed
Oliver, Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. 1997, Pubmed
Osborn, Immunofluorescence and immunocytochemical procedures with affinity purified antibodies: tubulin-containing structures. 1982, Pubmed
Otteken, Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin. 1996, Pubmed
Ou, Association of folding intermediates of glycoproteins with calnexin during protein maturation. 1993, Pubmed
Parker, Regenerative release of calcium from functionally discrete subcellular stores by inositol trisphosphate. 1991, Pubmed , Xenbase
Parker, Inhibition by Ca2+ of inositol trisphosphate-mediated Ca2+ liberation: a possible mechanism for oscillatory release of Ca2+. 1990, Pubmed , Xenbase
Parys, Presence of inositol 1,4,5-trisphosphate receptor, calreticulin, and calsequestrin in eggs of sea urchins and Xenopus laevis. 1994, Pubmed , Xenbase
Peterson, Transient, lectin-like association of calreticulin with folding intermediates of cellular and viral glycoproteins. 1995, Pubmed
Pozzan, Molecular and cellular physiology of intracellular calcium stores. 1994, Pubmed
Putney, The inositol phosphate-calcium signaling system in nonexcitable cells. 1993, Pubmed
Robb-Gaspers, Coordination of Ca2+ signaling by intercellular propagation of Ca2+ waves in the intact liver. 1995, Pubmed
Rodan, N-linked oligosaccharides are necessary and sufficient for association of glycosylated forms of bovine RNase with calnexin and calreticulin. 1996, Pubmed
Rooney, The endoplasmic reticulum in PC12 cells. Evidence for a mosaic of domains differently specialized in Ca2+ handling. 1996, Pubmed
Rooney, Intracellular calcium waves generated by Ins(1,4,5)P3-dependent mechanisms. 1993, Pubmed
Simpson, Mitochondria support inositol 1,4,5-trisphosphate-mediated Ca2+ waves in cultured oligodendrocytes. 1996, Pubmed
Sousa, The molecular basis for the recognition of misfolded glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase. 1995, Pubmed
Stendahl, Redistribution of intracellular Ca2+ stores during phagocytosis in human neutrophils. 1994, Pubmed
Stokes, Structure, transmembrane topology and helix packing of P-type ion pumps. 1994, Pubmed
Takei, Ca2+ stores in Purkinje neurons: endoplasmic reticulum subcompartments demonstrated by the heterogeneous distribution of the InsP3 receptor, Ca(2+)-ATPase, and calsequestrin. 1992, Pubmed
Tjoelker, Human, mouse, and rat calnexin cDNA cloning: identification of potential calcium binding motifs and gene localization to human chromosome 5. 1994, Pubmed
Treves, Calreticulin is a candidate for a calsequestrin-like function in Ca2(+)-storage compartments (calciosomes) of liver and brain. 1990, Pubmed
Vanlingen, Distribution of inositol 1,4,5-trisphosphate receptor isoforms, SERCA isoforms and Ca2+ binding proteins in RBL-2H3 rat basophilic leukemia cells. 1997, Pubmed
Verboomen, The functional importance of the extreme C-terminal tail in the gene 2 organellar Ca(2+)-transport ATPase (SERCA2a/b). 1994, Pubmed
Verboomen, Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban. 1992, Pubmed
Ware, The molecular chaperone calnexin binds Glc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins. 1995, Pubmed
Watanabe, Molecular cloning of a novel Ca(2+)-binding protein (calmegin) specifically expressed during male meiotic germ cell development. 1994, Pubmed
Williams, The Merck Frosst Award Lecture 1994/La conference Merck Frosst 1994. Calnexin: a molecular chaperone with a taste for carbohydrate. 1995, Pubmed
Wu, Localization and quantification of endoplasmic reticulum Ca(2+)-ATPase isoform transcripts. 1995, Pubmed
Zapun, Conformation-independent binding of monoglucosylated ribonuclease B to calnexin. 1997, Pubmed